TRT in Miami: What to Expect, What the Labs Actually Show

TRT in Miami: What to Expect, What the Labs Actually Show

By Dr. Victor Calvo, MD — Medical Director, Provena Care Internal Medicine · Miami, FL · Provena Care

The Problem With How TRT Is Usually Handled

Walk into most clinics that offer testosterone replacement therapy and you'll encounter one of two extremes.

The first is the rushed primary care visit — a doctor glances at your total testosterone, sees it's technically within the "normal" range, and sends you home with no further conversation. You feel exhausted, your motivation is gone, your body composition has shifted despite doing everything right, and you're told your labs are fine.

The second is the opposite extreme: a men's health clinic that puts everyone on TRT within the first visit, with minimal lab work, minimal monitoring, and a checkout cart full of supplements you didn't ask for.

Neither of these is medicine. Neither of these is what we do at Provena Care.

This article walks through what testosterone replacement therapy actually involves — the labs we order before starting, what the numbers mean, how we monitor you over time, and what a patient at Provena Care realistically experiences in months one, three, and six of treatment.

What Is TRT, Actually?

Testosterone replacement therapy is the medical administration of exogenous testosterone to men whose bodies are producing insufficient levels — a condition called hypogonadism. It is not a performance-enhancing drug program. It is not optional for men who simply want to feel better with normal testosterone levels. It is a medically indicated treatment for a documented hormonal deficiency that affects quality of life, metabolic health, cardiovascular function, bone density, cognition, and mood.

Low testosterone is more common than most men realize. Testosterone levels in men have been declining at a population level for decades — a trend attributed to environmental factors, chronic sleep disruption, metabolic dysfunction, and sedentary lifestyles. A 40-year-old man today has measurably lower testosterone than a 40-year-old man did in 1980, even controlling for age and body weight.

Symptoms of low testosterone include:

• Persistent fatigue that sleep doesn't resolve

• Reduced motivation, drive, and mental clarity

• Decreased muscle mass and increased body fat, particularly around the abdomen

• Reduced libido and sexual function

• Mood changes — irritability, low mood, emotional flatness

• Poor recovery from exercise

• Reduced bone density over time

The presence of these symptoms, combined with laboratory confirmation of low testosterone, is what drives a clinical decision to consider TRT. Symptoms alone are not enough. Labs alone are not enough. Both are required.

The Labs We Order Before Starting TRT

This is where Provena Care is meaningfully different from most clinics that offer testosterone therapy.

We do not start any patient on TRT based on total testosterone alone. Here is the complete panel we evaluate before making any treatment decision:

Total Testosterone

This is the starting point — the aggregate measure of all testosterone in your blood, both bound and unbound. Reference ranges vary slightly by lab, but most report "normal" as 300–1,000 ng/dL. The problem with this range is that it was established from population averages, not from clinical outcomes research on what levels are associated with symptom resolution and optimal function.

A man with a total testosterone of 310 ng/dL is technically "normal." He is also likely symptomatic, and his level places him at the absolute floor of a range that was never designed to represent optimal health.

Free Testosterone

This is the clinically critical number that most standard panels omit entirely.

Only 2–3% of circulating testosterone is "free" — unbound to carrier proteins and actually available to your tissues. A man can have a total testosterone of 500 ng/dL and still have functionally low testosterone if his free testosterone is suppressed. This happens when sex hormone-binding globulin (SHBG) is elevated — which becomes increasingly common with age, metabolic dysfunction, and thyroid disorders.

We calculate free testosterone from total testosterone, SHBG, and albumin using the Vermeulen formula, which provides a more accurate estimate than direct free testosterone assays.

SHBG — Sex Hormone-Binding Globulin

SHBG is the protein that binds testosterone and renders it biologically inactive. Elevated SHBG — which rises with age, liver function changes, hyperthyroidism, and caloric restriction — directly suppresses free testosterone even when total testosterone appears adequate.

Understanding a patient's SHBG level is essential for interpreting their testosterone status and for making dosing decisions if TRT is initiated.

Estradiol (E2)

Testosterone aromatizes — converts — into estradiol in fat tissue. This is a normal physiological process. The problem arises when estradiol rises disproportionately to testosterone, which can cause symptoms including water retention, mood instability, reduced libido, and gynecomastia.

We measure estradiol before starting TRT to establish a baseline and monitor it closely during treatment. Estradiol management is one of the most commonly mishandled aspects of TRT at low-quality clinics — either ignored entirely or over-suppressed with aromatase inhibitors, both of which create their own problems.

LH and FSH — Luteinizing Hormone and Follicle-Stimulating Hormone

These are the pituitary signals that tell the testes to produce testosterone. Measuring them before starting TRT tells us whether low testosterone is primary (the testes aren't responding) or secondary (the pituitary isn't signaling). This distinction matters for diagnosis, for fertility considerations, and for understanding whether endogenous production can be stimulated.

Once exogenous testosterone is introduced, LH and FSH will suppress — which is why baseline measurements matter before treatment begins.

PSA — Prostate-Specific Antigen

PSA is measured before starting TRT in men over 40 as a baseline for prostate health monitoring. TRT does not cause prostate cancer — the evidence on this has shifted substantially over the past two decades — but it can accelerate the growth of pre-existing prostate disease. Establishing a baseline PSA and monitoring it during treatment is standard clinical practice.

Hematocrit and Hemoglobin

Testosterone stimulates red blood cell production — an effect called erythrocytosis. In most patients this is mild and clinically insignificant. In some patients, particularly those on higher doses or with underlying conditions, hematocrit can rise to levels that increase blood viscosity and cardiovascular risk.

We measure hematocrit before starting TRT and monitor it at every follow-up. If it rises above 54%, we adjust the protocol.

Comprehensive Metabolic Panel and Lipid Panel

Baseline liver function, kidney function, fasting glucose, and lipid markers are part of every Provena pre-TRT evaluation. Testosterone affects lipid metabolism — typically lowering HDL modestly while improving other cardiovascular markers — and we want a clear pre-treatment baseline.

Additional Markers We Consider

Depending on the patient's symptom profile and history, we may also evaluate:

• Thyroid panel (TSH, Free T3, Free T4) — thyroid dysfunction is a common driver of fatigue and low libido that mimics hypogonadism

• Cortisol — chronic stress and HPA axis dysregulation suppress testosterone and must be addressed alongside any hormonal treatment

• Vitamin D — deficiency is strongly associated with low testosterone and is prevalent in South Florida despite the sunlight

• Fasting insulin and HbA1c — insulin resistance and metabolic dysfunction suppress testosterone and complicate treatment response

What "Optimal" Looks Like — And Why Normal Range Isn't the Goal

The laboratory reference range for total testosterone (300–1,000 ng/dL) represents the middle 95% of the population from which it was derived — a population that includes men of all ages, health statuses, and body compositions.

At Provena Care, we target functional optimization, not population averages. For most men on TRT, we aim for:

• Total testosterone: 700–1,000 ng/dL

• Free testosterone: Upper quartile of the reference range for age

• Estradiol: 20–30 pg/mL (sensitive assay)

• Hematocrit: Below 54%

• PSA: Stable relative to baseline

These are not arbitrary numbers. They are the ranges associated with symptom resolution, metabolic improvement, and acceptable safety margins in the clinical literature and in our own patient outcomes.

How TRT Is Administered at Provena Care

There are several delivery methods for testosterone replacement. We discuss all of them with each patient and choose based on lifestyle, preference, and clinical factors.

Intramuscular or subcutaneous injections — typically testosterone cypionate or enanthate, administered weekly or twice weekly. This is the most common method we use. Injections allow precise dosing, have the most robust evidence base, and avoid the transdermal absorption variability of topical formulations.

Topical gels and creams — applied daily to the skin. Convenient for patients who prefer to avoid injections. The primary limitation is variable absorption and the risk of transference to partners or children through skin contact.

Subcutaneous pellets — inserted under the skin every 3–6 months. Provide stable, consistent testosterone levels without weekly administration. A good option for patients who want a set-and-forget approach.

Oral testosterone — newer formulations (testosterone undecanoate) are FDA-approved and available. Less commonly used due to cost and the requirement for twice-daily dosing with a high-fat meal.

What to Expect — Month by Month

Month 1

The first month is not typically when patients feel dramatically different. Some men notice improved sleep quality and a modest increase in energy within the first two weeks. Libido often improves early. Mood stabilization is common.

What you will not see in month one: significant changes in body composition, strength, or muscle mass. Those changes require time and consistent training alongside hormonal optimization.

We schedule a follow-up lab draw and telehealth visit at 4–6 weeks to check testosterone, estradiol, and hematocrit. Dosing adjustments are made based on these results.

Month 3

By month three, most men are experiencing meaningful changes. Energy is more consistent throughout the day. Motivation and mental clarity are often noticeably improved. Body composition begins to shift — fat around the abdomen starts to mobilize, and muscle tissue responds more efficiently to resistance training.

Libido and sexual function are typically well-improved by this point. Mood is generally more stable.

We run a comprehensive follow-up panel at 12 weeks: total testosterone, free testosterone, estradiol, SHBG, hematocrit, PSA (in men over 40), and metabolic markers. Protocol adjustments are made if needed.

Month 6

Six months is when most patients describe feeling like a meaningfully different version of themselves. Body composition changes are visible. Strength and recovery from exercise are substantially improved. Energy, mood, and cognitive function are consistently better than the pre-treatment baseline.

This is also when we assess whether any protocol modifications — dose, frequency, delivery method — are needed for long-term maintenance.

TRT and Fertility — What You Need to Know

This is one of the most important conversations we have before starting TRT with any patient who may want biological children in the future.

Exogenous testosterone suppresses LH and FSH, which suppresses sperm production. For men who are not currently trying to conceive and do not plan to, this is clinically manageable. For men who want to preserve fertility, we discuss alternative protocols — including clomiphene citrate and human chorionic gonadotropin (hCG) — that can support testosterone levels while maintaining endogenous production and spermatogenesis.

This conversation happens before we start treatment, not after. If fertility is relevant to you, tell us at your first visit.

What TRT Does Not Do

We are direct with our patients about the limitations of testosterone replacement therapy, because unrealistic expectations lead to patient dissatisfaction and poor outcomes.

TRT does not replace sleep. If you are sleeping 5 hours a night, testosterone will not compensate for the hormonal disruption that sleep deprivation causes.

TRT does not replace training. Testosterone creates an anabolic environment. What you do in that environment — how you train and recover — determines the results.

TRT does not fix metabolic dysfunction on its own. If insulin resistance, obesity, or chronic inflammation are driving your low testosterone, those conditions need to be addressed directly alongside hormonal optimization. This is why Provena's approach integrates metabolic health management with hormone health, rather than treating them as separate categories.

TRT is not a permanent commitment. If you decide to discontinue, we manage the process carefully — including post-TRT recovery protocols if appropriate.

Is TRT Right for You?

The answer depends entirely on your labs, your symptoms, your health history, and your goals. It is not a decision that should be made in a 10-minute appointment based on a single testosterone number.

At Provena Care, the evaluation process is thorough because the decision is consequential. We order the right labs, interpret them in the context of your full clinical picture, and build a protocol — if one is warranted — around your specific biology and lifestyle.

If you have been experiencing the symptoms described in this article and want to know what your labs actually show, the first step is a conversation.

Provena Care 10251 SW 72nd St, Suite 106 · Miami, FL 33173 305.395.7108 · info@provenacare.com

Performance and Elite membership tiers include TRT management and quarterly hormone optimization telehealth. Core members receive a discounted longevity consultation. View membership plans.